戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 relieving an inhibition imposed by a 100-kDa phosphotyrosine phosphatase.
2 ncrease pp68 phosphorylation by inhibiting a phosphotyrosine phosphatase.
3  nuclear DNA, rather than by inhibition of a phosphotyrosine phosphatase.
4 logical role in the activation of a membrane phosphotyrosine phosphatase.
5 alyzed phosphorylation is counterbalanced by phosphotyrosine phosphatases.
6 d with sodium orthovanadate, an inhibitor of phosphotyrosine phosphatases.
7  activity and suggested the involvement of a phosphotyrosine phosphatase 1b (PTP1b) in this process.
8  VEGFR2 by calpain via its substrate protein phosphotyrosine phosphatase 1B (PTP1B), and the relevanc
9 on of suppressor of cytokine signaling-3 and phosphotyrosine phosphatase 1B, two negative regulators
10                      Src homology containing phosphotyrosine phosphatase 2 (SHP2) is a positive effec
11 3-kinase (PI3K) or SRC homology 2-containing phosphotyrosine phosphatase 2 (SHP2).
12 9, 81, and 84 in Acr2p resulted in a gain of phosphotyrosine phosphatase activity and a loss of arsen
13 tion of substrate specificity, with enhanced phosphotyrosine phosphatase activity and decreased phosp
14 43-mediated apoptosis, whereas inhibition of phosphotyrosine phosphatase activity by bis(maltolato)ox
15 w that CD5 is constitutively associated with phosphotyrosine phosphatase activity in Jurkat T cells.
16  Tyr-1510 were phosphorylated on IQGAP1 when phosphotyrosine phosphatase activity was inhibited in ce
17 rmore, peroxovanadate, a potent inhibitor of phosphotyrosine phosphatase activity, inhibited ICl acti
18 ects are presumably due to the inhibition of phosphotyrosine phosphatase activity.
19     FSH promotes the phosphorylation of this phosphotyrosine phosphatase and its dissociation from ER
20                   Interactions between SHP-2 phosphotyrosine phosphatase and JAK tyrosine kinases hav
21 taurosporine, inhibitors of tyrosine kinase, phosphotyrosine phosphatase, and protein kinase C, respe
22  phosphotyrosine signaling-tyrosine kinases, phosphotyrosine phosphatases, and Src Homology 2 (SH2) d
23       Shp-2, a src homology (SH)2-containing phosphotyrosine phosphatase, appears to be involved in c
24  smooth muscle cells in which Gi and protein-phosphotyrosine phosphatase are involved, resulting in t
25 ssays, which are done under conditions where phosphotyrosine phosphatases are inhibited and receptor
26                            Expression of the phosphotyrosine phosphatase CD45 is essential for B cell
27                    The SH2 domain-containing phosphotyrosine phosphatase Corkscrew (CSW) is an essent
28             Sodium vanadate, an inhibitor of phosphotyrosine phosphatases, did not reverse the defici
29 g portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved
30 ich is stimulated by Ephrin A1 (EfnA1) or by phosphotyrosine phosphatase inhibition.
31                           Treatment with the phosphotyrosine phosphatase inhibitor bis(maltolato)oxov
32 fect of methoxamine was also mimicked by the phosphotyrosine phosphatase inhibitor pervanadate (PVN).
33             Treatment of adipocytes with the phosphotyrosine phosphatase inhibitor phenylarsine oxide
34                                 The specific phosphotyrosine phosphatase inhibitor, bpV(phen), dimini
35             Inclusion of bpV(phen), a potent phosphotyrosine phosphatase inhibitor, in the recording
36                                     A second phosphotyrosine phosphatase inhibitor, phenylarsine oxid
37 lication of pervanadate, an extremely potent phosphotyrosine phosphatase inhibitor, provokes the rapi
38                              Conversely, the phosphotyrosine phosphatase inhibitor, sodium vanadate,
39                 Moreover, treatment with the phosphotyrosine-phosphatase inhibitor potassium bisperox
40              Jurkat T cells activated by the phosphotyrosine phosphatase inhibitors H2O2 or vanadate
41 oietic cytokine, and CD45RA, an isoform of a phosphotyrosine phosphatase involved in negative regulat
42 homology 2 domain tyrosine phosphatase 1), a phosphotyrosine phosphatase, is considered an important
43 eviously identified for binding by the SHP-2 phosphotyrosine phosphatase.JAK2 tyrosine kinase complex
44                            LAR-type receptor phosphotyrosine-phosphatases (LAR-RPTPs) are presynaptic
45  and the recruitment of low-molecular-weight phosphotyrosine phosphatase (LMW-PTP) to receptor comple
46 d EGF binding affinity, or the presence of a phosphotyrosine phosphatase or ATPase.
47  SH2 protein tyrosine phosphatase 2 (SHPTP2) phosphotyrosine phosphatase plays a key role in preventi
48                  In contrast, inhibiting the phosphotyrosine phosphatase protein tyrosine phosphatase
49 t LMWCr isolated from bovine liver activates phosphotyrosine phosphatase (PTP) activity in adipocyte
50 idative stress in the mechanism of action of phosphotyrosine phosphatase (PTP) inhibitors was studied
51                        Direct measurement of phosphotyrosine phosphatase (PTPase) activity in SUM-52P
52                     The low molecular weight phosphotyrosine phosphatases (PTPases) constitute a dist
53                                              Phosphotyrosine phosphatases (PTPases) regulate cellular
54 cal probes for second-site screening against phosphotyrosine phosphatases (PTPs) using NMR-based tech
55 conserved catalytic site sequence of protein phosphotyrosine phosphatases (PTPs), VXVHCXXGXXR, at ami
56 uramin, a heparin analogue, or inhibitors of phosphotyrosine phosphatases (PTPs; vanadate or calpepti
57 These results suggest that SFKs and putative phosphotyrosine phosphatases regulate the activity of AC
58 logy 2 (SH2) domain containing hematopoietic phosphotyrosine phosphatase SHP-1 in both Jurkat cells a
59 mechanism, in addition to recruitment of the phosphotyrosine phosphatase SHP-1, by which secreted imm
60 g in hematopoietic cells is regulated by the phosphotyrosine phosphatase SHP-1, which is not implied
61 ), phosphatidylinositol 3-kinase (PI3K), the phosphotyrosine phosphatase SHP-2, Grb2, and Src.
62 ymes including Src family members (Src), the phosphotyrosine phosphatase SHP-2, phosphatidylinositol
63 ositol phosphatase (SHIP) and SH2-containing phosphotyrosine phosphatase (SHP)-1, as well as SHP-2 as
64 nd inactivation of Src homology 2-containing phosphotyrosine phosphatase (SHP-2).
65                                              Phosphotyrosine phosphatase Shp2 has been shown to depho
66         The Src homology 2 domain-containing phosphotyrosine phosphatase (SHP2) is a critical mediato
67                The Src homology 2-containing phosphotyrosine phosphatase (SHP2) is primarily a positi
68 pha1 and the Src homology-2 (SH2)-containing phosphotyrosine phosphatase, SHP2.
69  C gamma, Ras GTPase-activating protein, and phosphotyrosine phosphatase SHPTP2.
70 itors suggests the involvement of a membrane phosphotyrosine phosphatase similar to PTP1A' or PTP1B.
71  restrained at the level of ERK by a 100-kDa phosphotyrosine phosphatase that associates with ERK in
72  also shown to activate by 3-4-fold SHP-1, a phosphotyrosine phosphatase that contains two src homolo
73 effector molecules including SHP-1, a potent phosphotyrosine phosphatase that down-regulates B cell a
74  (PTPases) constitute a distinctive class of phosphotyrosine phosphatases that is widely distributed
75 d by either phosphoprotein phosphatase 2A or phosphotyrosine phosphatase type 1.
76 ing mechanism was ROS-mediated inhibition of phosphotyrosine phosphatases, which antagonize receptor
77 ibing an activation-induced association of a phosphotyrosine phosphatase with tyrosine-phosphorylated
78              Shp-1 and Shp-2 are cytoplasmic phosphotyrosine phosphatases with similar structures.